NCT03716622View on ClinicalTrials.gov

A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication

PHASE4CompletedINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions

Helicobacter Pylori

Interventions

DRUG

Furazolidone

bismuth-furazolidone-containing quadruple regimens

DRUG

Clarithromycin

bismuth-clarithromycin-containing quadruple regimens

Trial Locations (1)

257000

Qilu hosipital, Jinan

All Listed Sponsors

lead

Shandong University

OTHER

NCT03716622 - A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication | Biotech Hunter | Biotech Hunter